A review of toxicity from topical salicylic acid preparations

Journal of the American Academy of Dermatology

Volumn 70, Issue 4, 2014, Pages 788-792

  Madan, Raman K ^a,b   Levitt, Jacob ^b  

^a MOUNT SINAI HEALTH SYSTEM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

ichthyosis; psoriasis; salicylic acid; salicylism; skin absorption; topical; toxicity

Indexed keywords

SALICYLIC ACID;

AGITATION; ANOREXIA; ARTICLE; COMA; CONFUSION; CONSCIOUSNESS DISORDER; DIZZINESS; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG FATALITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOXICITY; DYSPNEA; ERYTHRODERMA; FEVER; HALLUCINATION; HEADACHE; HEARING IMPAIRMENT; HEART FAILURE; HUMAN; HYPERTHERMIA; HYPERVENTILATION; HYPOGLYCEMIA; ICHTHYOSIS; KIDNEY FAILURE; MALAISE; METABOLIC ACIDOSIS; NAUSEA; PH; PRIORITY JOURNAL; PSORIASIS; RESPIRATORY ALKALOSIS; SEBORRHEIC DERMATITIS; SOMNOLENCE; TACHYCARDIA; TACHYPNEA; THIRST; TINEA IMBRICATA; TINNITUS; TRANSCELLULAR FLUID; VERTIGO; VOMITING; WHEEZING; XEROSTOMIA;

ICHTHYOSIS; PSORIASIS; SALICYLIC ACID; SALICYLISM; SKIN ABSORPTION; TOPICAL; TOXICITY;

ADMINISTRATION, TOPICAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; ICHTHYOSIS; KERATOLYTIC AGENTS; MALE; PROGNOSIS; PSORIASIS; RISK ASSESSMENT; SALICYLIC ACID; SKIN ABSORPTION; SURVIVAL ANALYSIS;

EID: 84896069685     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.12.005     Document Type: Review

References (40)

1. Tilo Grosser ES, FitzGerald GA. Anti-Inflammatory, antipyretic, and analgesic agents. In: Brunton LL, editor. Goodman and Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill Co; 2011. pp. 977-82.
2. Daintith EJ. Aspirin. Oxford University Press; 2008. Available from: URL http://www.oxfordreference.com/views/ENTRY.html?subview=Main&entry=t81. e4554. Accessed August 17, 2012.
3. Palleros DR. Experimental organic chemistry. New York: John Wiley and Sons; 2000.
4. Lipster D, Kragballe K, Saurat JH. Other topical medications. In: Bolognia JL, Rapini RP, editors. Dermatology. 1st ed. Philadelphia: Elsevier Limited; 2003. p. 2062.
5. Freeberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill; 2003.
6. Hessel A, Lin A. Agents used for treatment of hyperkeratosis. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 1st ed. Philadelphia: Saunders; 2001. pp. 671-4.
7. Schwarb FP, Gabard B, Rufli T, Surber C. Percutaneous absorption of salicylic acid in man after topical administration of three different formulations. Dermatology 1999;198:44-51. (Pubitemid 29086334)
8. Taylor JR, Halprin KM. Percutaneous absorption of salicylic acid. Arch Dermatol 1975;111:740-3.
9. Birmingham BK, Greene DS, Rhodes CT. Systemic absorption of topical salicylic acid. Int J Dermatol 1979;18:228-31. (Pubitemid 9162200)
10. Benfeldt E, Serup J, Menné T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999;140:739-48. (Pubitemid 29191402)
11. Klimowicz A, Farfal S, Bielecka-Grzela S. Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs salicylic acid. J Clin Pharm Ther 2007;32:143-8. (Pubitemid 46449702)
12. Singh P, Roberts MS. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 1994;268:144-51. (Pubitemid 24039081)
13. Long CC, Finlay AY. The finger-tip unit - a new practical measure. Clin Exp Dermatol 1991;16:444-7.
14. VonWeiss JF, Lever WF. Percutaneous salicylic acid intoxication in psoriasis. Arch Dermatol 1964;90:614-9.
15. Higashi Y, Kiuchi T, Furuta K. Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: a randomized, double-blind, parallel-group, placebo-controlled, multicenter study. Clin Ther 2010;32:34-43.
16. Martin D, Valdez J, Boren J, Mayersohn M. Dermal absorption of camphor, menthol, and methyl salicylate in humans. J Clin Pharmacol 2004;44:1151-7. (Pubitemid 39202459)
17. Davis JE. Are one or two dangerous? Methyl salicylate exposure in toddlers. Emerg Med 2007;32:63-9. (Pubitemid 46097392)
18. Torloni MR, Cordioli E, Zamith MM, Hisaba WJ, Nardozza LM, Santana RM, et al. Reversible constriction of the fetal ductus arteriosus after maternal use of topical diclofenac and methyl salicylate. Ultrasound Obstet Gynecol 2006;27:227-9. (Pubitemid 43733744)
19. Bell AJ, Duggin G. Acute methyl salicylate toxicity complicating herbal skin treatment for psoriasis. Emerg Med (Fremantle) 2002;14:188-90. (Pubitemid 34717329)
20. Heng MC. Local necrosis and interstitial nephritis due to topical methyl salicylate and menthol. Cutis 1987;39:442-4. (Pubitemid 17099302)
21. Joss JD, LeBlond RF. Potentiation of warfarin anticoagulation associated with topical methyl salicylate. Ann Pharmacother 2000;34:729-33. (Pubitemid 30395771)
22. Oualha M, Dupic L, Bastian C, Bergounioux J, Bodemer C, Lesage F. Local salicylate transcutaneous absorption: an unrecognized risk of severe intoxication; a case report [in French]. Arch Pediatr 2012;19:1089-92.
23. Chodorowski Z, Anand JS, Waldman W. Suicidal salicylate intoxications and unintentional percutaneous poisoning with salicylic ointment [in Polish]. Przegl Lek 2003;60:302-4.
24. Yamamura S, Kinoshita Y, Kitamura N, Kawai S, Kobayashi Y. Neonatal salicylate poisoning during the treatment of a collodion baby. Clin Pediatr 2002;41:451-2. (Pubitemid 34809407)
25. Peyriere H, Balmes N, Rouanet I, Mauboussin JM, Hillaire-Buys D, Arich C, et al. Acute salicylate intoxication after percutaneous absorption in an HIV patient treated for psoriasis. AIDS 2002;16:1843-4.
26. Chiaretti A, Schembri Wismayer D, Tortorolo L, Piastra M, Polidori G. Salicylate intoxication using a skin ointment. Acta Paediatr 1997;86:330-1. (Pubitemid 27135286)
27. Germann R, Schindera I, Kuch M, Seitz U, Altmeyer S, Schindera F. Life threatening salicylate poisoning caused by percutaneous absorption in severe ichthyosis vulgaris. Hautarzt 1996;47:624-7. (Pubitemid 26272793)
28. Brubacher JR, Hoffman RS. Salicylism from topical salicylates: review of the literature. J Toxicol Clin Toxicol 1996;34:431-6.
29. Abdel-Magid EH, el-Awad Ahmed FR. Salicylate intoxication in an infant with ichthyosis transmitted through skin ointment - a case report. Pediatrics 1994;94:939-40. (Pubitemid 24359204)
30. Maurer TA, Winter ME, Koo J, Berger TG. Refractory hypoglycemia: a complication of topical salicylate therapy. Arch Dermatol 1994;130:1455-7. (Pubitemid 24345799)
31. Dwyer CM, McCloskey RH, Kerr RE. Poisoning from topical salicylic acid. Postgrad Med J 1994;70:146.
32. Péc J, Strmenova M, Palencárová E, Pullmann R, Funiaková S, Visnovský P, et al. Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis. Cutis 1992;50:307-9.
33. Raschke R, Arnold-Capell PA, Richeson R, Curry SC. Refractory hypoglycemia secondary to topical salicylate intoxication. Arch Intern Med 1991;151:591-3.
34. Galea P, Goel KM. Salicylate poisoning in dermatological treatment [letter]. Arch Dis Child 1990;65:335. (Pubitemid 20108919)
35. Ward PS, Jones RD. Successful treatment of a harlequin fetus. Arch Dis Child 1989;64:1309-11. (Pubitemid 19220780)
36. Shupp DL, Schroeter AL. An unusual case of salicylate toxicity [letter]. J Am Acad Dermatol 1986;15:300-1. (Pubitemid 16070360)
37. Treguer H, Le Bihan G, Coloignier M, Le Roux P, Bernard JP. Salicylate poisoning by local application of 20% salicylic acid petrolatum to a psoriatic patient [in French]. Nouve Presse Med 1980;9:192-3. (Pubitemid 10185853)
38. Davies MG, Briffa DV, Greaves MW. Systemic toxicity from topically applied salicylic acid. Br Med J 1979;1:661. (Pubitemid 9145052)
39. Luderschmidt C, Plewig G. Chronic percutaneous salicylic acid poisoning [in German]. Hautarzt 1975;26:643-6.
40. Lindsey CP. Two cases of fatal salicylate poisoning after topical application of an antifungal solution. Med J Aust 1968;1:353-4.